Examples of targeted therapies include monoclonal antibodies, which can recognize and bind to specific proteins on the surface of cancer cells, and small molecule inhibitors, which can enter cells and interfere with the function of proteins involved in cancer cell growth. Notable drugs include Imatinib for chronic myeloid leukemia and Trastuzumab for HER2-positive breast cancer.
